Jose M. Miro

Impact of interrupting ART started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: the SPARTAC trial

P. Kaleebu, A. Heslegrave, J. Frater, 2024, Journal of Virus Eradication.